Skip to main content
Premium Trial:

Request an Annual Quote

Axys Subsidiary Merges With Discovery Partners

Premium

SOUTH SAN FRANCISCO, Calif.--Axys Pharmaceuticals announced that the merger of its combinatorial chemistry subsidiary, Axys Advanced Technologies, with Discovery Partners International has been completed. Axys received approximately $60 million in Discovery stock as consideration for its interest in the Axys subsidiary.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.